Latest News and Press Releases
Want to stay updated on the latest news?
-
Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum
-
Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026
-
Lifecore Biomedical and Indomo sign new agreement to support innovative drug/device combination acne treatment.
-
CHASKA, Minn., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”),...
-
Grabar Law Office is investigating claims on behalf of shareholders of Lifecore Biomedical, Inc. (NASDAQ: LFCR) as a securities fraud class action settles.
-
PHILADELPHIA, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Ibotta, Inc. (NYSE: IBTA): WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Ibotta, Inc. (NYSE: IBTA). The...
-
Ibatta (NYSE: IBTA); Integer Holdings (NYSE: ITGR); Lifecore Biomedical (NASDAQ: LFCR); and Molina Healthcare (NYSE: MOH) Shareholder Investigations
-
PHILADELPHIA, Jan. 22, 2026 (GLOBE NEWSWIRE) -- CoreWeave, Inc. (NASDAQ: CRWV) Grabar Law Office is investigating claims on behalf of shareholders of CoreWeave, Inc. (NASDAQ: CRWV). The...
-
PHILADELPHIA, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is investigating claims on behalf of shareholders of Ibotta, Inc. (NYSE: IBTA). The investigation...
-
PHILADELPHIA, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is investigating claims on behalf of shareholders of Ibotta, Inc. (NYSE: IBTA). The investigation...